Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

ZNF703 is an important player in head and neck cancer.

Orhan C, Bakır B, Dalay N, Buyru N.

Clin Otolaryngol. 2019 Nov;44(6):1080-1086. doi: 10.1111/coa.13450. Epub 2019 Oct 23.

PMID:
31574205
2.

Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.

Orhan C, Bulut P, Dalay N, Ersen E, Buyru N.

Mol Biol Rep. 2019 Oct;46(5):5251-5256. doi: 10.1007/s11033-019-04982-6. Epub 2019 Jul 18.

PMID:
31321645
3.

Detection of RB1 Gene Copy Number Variations Using a Multiplex Ligation-Dependent Probe Amplification Method.

Dalay N.

Methods Mol Biol. 2018;1726:7-18. doi: 10.1007/978-1-4939-7565-5_2.

PMID:
29468539
4.

The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis.

Baykara O, Dalay N, Bakir B, Bulut P, Kaynak K, Buyru N.

Int J Med Sci. 2017 Jun 23;14(7):675-679. doi: 10.7150/ijms.19355. eCollection 2017.

5.

ZNF703 Overexpression may act as an oncogene in non-small cell lung cancer.

Baykara O, Dalay N, Kaynak K, Buyru N.

Cancer Med. 2016 Oct;5(10):2873-2878. doi: 10.1002/cam4.847. Epub 2016 Sep 20.

6.

Copy number profiling of tumor suppressor genes in head and neck cancer.

Yalniz Z, Demokan S, Karabulut B, Ulusan M, Suoglu Y, Dalay N.

Head Neck. 2017 Feb;39(2):341-346. doi: 10.1002/hed.24593. Epub 2016 Oct 3.

PMID:
27696595
7.

Analysıs of gene copy number changes ın head and neck cancer.

Baltaci E, Karaman E, Dalay N, Buyru N.

Clin Otolaryngol. 2018 Aug;43(4):1004-1009. doi: 10.1111/coa.12686. Epub 2016 Jun 4.

PMID:
27259694
8.

MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.

Yoruker EE, Terzioglu D, Teksoz S, Uslu FE, Gezer U, Dalay N.

J Cancer. 2016 Apr 26;7(7):803-9. doi: 10.7150/jca.13898. eCollection 2016.

9.

Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

Yoruker EE, Aydoğan F, Gezer U, Saip P, Dalay N.

Mol Clin Oncol. 2015 Jul;3(4):954-958. Epub 2015 May 13.

10.

Global quantification of heterochromatin-associated histone methylations in cell lines with differential sensitivity to ionizing radiation.

Cetinkaya M, Özgür E, Dalay N, Gezer U.

Acta Biochim Pol. 2015;62(2):173-6. doi: 10.18388/abp.2014_790. Epub 2015 May 26.

11.

Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease.

Işın M, Uysaler E, Özgür E, Köseoğlu H, Şanlı Ö, Yücel ÖB, Gezer U, Dalay N.

Front Genet. 2015 May 6;6:168. doi: 10.3389/fgene.2015.00168. eCollection 2015.

12.

Assessment of circulating serum DNA integrity in colorectal cancer patients.

Yörüker EE, Özgür E, Keskin M, Dalay N, Holdenrieder S, Gezer U.

Anticancer Res. 2015 Apr;35(4):2435-40.

PMID:
25862911
13.

LncRNAs and neoplasia.

Isin M, Dalay N.

Clin Chim Acta. 2015 Apr 15;444:280-8. doi: 10.1016/j.cca.2015.02.046. Epub 2015 Mar 5. Review.

PMID:
25748036
14.

Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells.

Gezer U, Tiryakioglu D, Bilgin E, Dalay N, Holdenrieder S.

Cell J. 2015 Winter;16(4):488-93. Epub 2015 Jan 13.

15.

Amplification of chromosome 8 genes in lung cancer.

Baykara O, Bakir B, Buyru N, Kaynak K, Dalay N.

J Cancer. 2015 Jan 20;6(3):270-5. doi: 10.7150/jca.10638. eCollection 2015.

16.

Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma.

Yalniz Z, Tigli H, Tigli H, Sanli O, Dalay N, Buyru N.

Tumour Biol. 2014 Dec;35(12):12361-8. doi: 10.1007/s13277-014-2550-4. Epub 2014 Sep 2.

PMID:
25179843
17.

Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.

Gezer U, Keskin S, Iğci A, Tükenmez M, Tiryakioğlu D, Cetinkaya M, Dişci R, Dalay N, Eralp Y.

Oncol Lett. 2014 Aug;8(2):845-848. Epub 2014 May 28.

18.

Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes.

Gezer U, Özgür E, Cetinkaya M, Isin M, Dalay N.

Cell Biol Int. 2014 Sep;38(9):1076-9. doi: 10.1002/cbin.10301. Epub 2014 May 13.

PMID:
24798520
19.

miR-141 and miR-375 induction and release are different from PSA mRNA and PCA3 upon androgen stimulation of LNCaP cells.

Tiryakioglu D, Bilgin E, Holdenrieder S, Dalay N, Gezer U.

Biomed Rep. 2013 Sep;1(5):802-806. Epub 2013 Jul 15.

20.

Investigation of circulating lncRNAs in B-cell neoplasms.

Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, Dalay N.

Clin Chim Acta. 2014 Apr 20;431:255-9. doi: 10.1016/j.cca.2014.02.010. Epub 2014 Feb 26.

PMID:
24583225
21.

LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.

Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N.

Transl Res. 2013 Aug;162(2):122-9. doi: 10.1016/j.trsl.2013.06.001. Epub 2013 Jun 25.

PMID:
23810581
22.

Promoter and histone methylation and p16(INK4A) gene expression in colon cancer.

Yoruker EE, Mert U, Bugra D, Yamaner S, Dalay N.

Exp Ther Med. 2012 Nov;4(5):865-870. Epub 2012 Aug 24.

23.

Induction of p53-inducible microRNA miR-34 by gamma radiation and bleomycin are different.

Mert U, Ozgür E, Tiryakioglu D, Dalay N, Gezer U.

Front Genet. 2012 Oct 19;3:220. doi: 10.3389/fgene.2012.00220. eCollection 2012.

24.

Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.

Gezer U, Ustek D, Yörüker EE, Cakiris A, Abaci N, Leszinski G, Dalay N, Holdenrieder S.

Tumour Biol. 2013 Feb;34(1):329-36. doi: 10.1007/s13277-012-0554-5. Epub 2012 Oct 20.

PMID:
23086575
25.

Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients.

Gezer U, Mert U, Ozgür E, Yörüker EE, Holdenrieder S, Dalay N.

Oncol Lett. 2012 May;3(5):1095-1098. Epub 2012 Feb 10.

26.

Role of DNA methylation in head and neck cancer.

Demokan S, Dalay N.

Clin Epigenetics. 2011 Aug;2(2):123-50. doi: 10.1007/s13148-011-0045-3. Epub 2011 Jul 9.

27.

Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells.

Özgür E, Mert U, Isin M, Okutan M, Dalay N, Gezer U.

Clin Exp Med. 2013 May;13(2):119-26. doi: 10.1007/s10238-012-0181-x. Epub 2012 Apr 10.

PMID:
22487937
28.

Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Eralp Y, Keskin S, Akışık E, Akışık E, İğci A, Müslümanoğlu M, Yılmaz S, Tunacı M, Çamlıca H, Tuzlalı S, Saip P, Dalay N, Özmen V, Topuz E.

Am J Clin Oncol. 2013 Jun;36(3):215-23. doi: 10.1097/COC.0b013e318243913f.

PMID:
22441341
29.

Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.

Demokan S, Chuang A, Suoğlu Y, Ulusan M, Yalnız Z, Califano JA, Dalay N.

Head Neck. 2012 Oct;34(10):1470-5. doi: 10.1002/hed.21949. Epub 2011 Nov 22.

PMID:
22106032
30.

Analysis of p53 tumor suppressor pathway genes in chronic lymphocytic leukemia.

Isin M, Yenerel M, Aktan M, Buyru N, Dalay N.

DNA Cell Biol. 2012 May;31(5):777-82. doi: 10.1089/dna.2011.1314. Epub 2011 Nov 2.

PMID:
22047081
31.

Genetic alterations of the WWOX gene in breast cancer.

Ekizoglu S, Muslumanoglu M, Dalay N, Buyru N.

Med Oncol. 2012 Sep;29(3):1529-35. doi: 10.1007/s12032-011-0080-0. Epub 2011 Oct 8.

PMID:
21983861
32.

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer.

Yaman Agaoglu F, Kovancilar M, Dizdar Y, Darendeliler E, Holdenrieder S, Dalay N, Gezer U.

Tumour Biol. 2011 Jun;32(3):583-8. doi: 10.1007/s13277-011-0154-9. Epub 2011 Jan 28.

PMID:
21274675
33.

Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer.

Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N.

DNA Cell Biol. 2011 Jan;30(1):17-24. doi: 10.1089/dna.2010.1090. Epub 2010 Sep 22.

PMID:
20860434
34.

Analysis of β-catenin alterations in colon tumors: a novel exon 3 mutation.

Akisik E, Buğra D, Yamaner S, Dalay N.

Tumour Biol. 2011 Feb;32(1):71-6. doi: 10.1007/s13277-010-0099-4. Epub 2010 Aug 18.

PMID:
20717765
35.

Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.

Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, Dalay N, Santella RM.

Anticancer Res. 2010 Jul;30(7):2489-96.

36.

Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.

Deligezer U, Yaman F, Darendeliler E, Dizdar Y, Holdenrieder S, Kovancilar M, Dalay N.

Clin Chim Acta. 2010 Oct 9;411(19-20):1452-6. doi: 10.1016/j.cca.2010.05.040. Epub 2010 Jun 2.

PMID:
20573596
37.

Analysis of the hMSH2 gene variants in head and neck cancer.

Demokan S, Suoglu Y, Ulusan M, Dalay N.

DNA Cell Biol. 2010 Aug;29(8):449-57. doi: 10.1089/dna.2009.1013.

PMID:
20438357
38.

ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.

Akisik E, Yazici H, Dalay N.

Mol Biol Rep. 2011 Jan;38(1):343-8. doi: 10.1007/s11033-010-0113-3. Epub 2010 Apr 1.

PMID:
20358297
39.

Assessment of microsatellite instability in head and neck cancer using consensus markers.

Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N.

Mol Biol Rep. 2010 Oct;37(7):3541-5. doi: 10.1007/s11033-010-0001-x. Epub 2010 Feb 25.

PMID:
20182807
40.
41.

N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.

Demokan S, Suoglu Y, Gözeler M, Demir D, Dalay N.

Mol Biol Rep. 2010 Oct;37(7):3217-26. doi: 10.1007/s11033-009-9905-8. Epub 2009 Nov 8.

PMID:
19898993
42.

Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups.

Yazici H, Zipprich J, Peng T, Akisik EZ, Tigli H, Isin M, Akisik EE, Terry MB, Senie RT, Li L, Peng M, Liu Z, Dalay N, Santella RM.

J Oncol. 2009;2009:827532. doi: 10.1155/2009/827532. Epub 2009 Oct 26.

43.

Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients.

Salepci T, Yazici H, Dane F, Topuz E, Dalay N, Onat H, Aykan F, Seker M, Aydiner A.

J BUON. 2009 Jul-Sep;14(3):495-9.

PMID:
19810144
44.

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D.

PLoS One. 2009 Aug 7;4(8):e6555. doi: 10.1371/journal.pone.0006555.

45.

Methylation profiles in breast cancer.

Buyru N, Altinisik J, Ozdemir F, Demokan S, Dalay N.

Cancer Invest. 2009 Mar;27(3):307-12. doi: 10.1080/07357900802350814.

PMID:
19194828
46.

Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer.

Deligezer U, Eralp Y, Akisik EZ, Akisik EE, Saip P, Topuz E, Dalay N.

Ann N Y Acad Sci. 2008 Aug;1137:175-9. doi: 10.1196/annals.1448.010.

PMID:
18837944
47.

p53 codon 72 polymorphism and HPV status in lung cancer.

Buyru N, Altinisik J, Isin M, Dalay N.

Med Sci Monit. 2008 Sep;14(9):CR493-7.

PMID:
18758421
48.

Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma.

Deligezer U, Akisik EE, Erten N, Dalay N.

Clin Chem. 2008 Jul;54(7):1125-31. doi: 10.1373/clinchem.2007.101766. Epub 2008 May 16.

PMID:
18487283
49.

Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy.

Deligezer U, Eralp Y, Akisik EE, Akisik EZ, Saip P, Topuz E, Dalay N.

Clin Chem Lab Med. 2008;46(3):311-7. doi: 10.1515/CCLM.2008.080.

PMID:
18254709
50.

Expression of the TRAIL receptors in blood mononuclear cells in leukemia.

Deligezer U, Dalay N.

Pathol Oncol Res. 2007;13(4):290-4. Epub 2007 Dec 25.

Supplemental Content

Support Center